logo

For the Inventor, By the Inventor

Belfast, United Kingdom

Cv6 Therapeutics (Ni) Limited

Calculating rank
USPTO Granted Patents = 18

% Expired Patents = 5.6

Forward Citations = 113

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Mark Spyvee (17 out of 39 patents)

silverMedal Pravin S Shirude (11 out of 11 patents)

bronzeMedal Robert D Ladner (8 out of 14 patents)

4.  Michael D Lewis (1 out of 10 patents)


18 patents:

1. 12098133 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2024-09-24),
2. 11584723 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2023-02-21),
3. 11518746 - Nitrogen ring linked deoxyuridine triphosphatase inhibitors (2022-12-06),
4. 11479531 - Deoxyuridine triphosphatase inhibitors (2022-10-25),
5. 11247984 - Uracil containing compounds (2022-02-15),
6. 11198677 - Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage (2021-12-14),
7. 11174271 - 6-membered uracil isosteres (2021-11-16),
8. 11168059 - Amino sulfonyl compounds (2021-11-09),
9. 11124485 - Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage (2021-09-21),
10. 11104649 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2021-08-31),
11. 11014924 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2021-05-25),
12. 10858344 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2020-12-08),
13. 10829457 - Nitrogen ring linked deoxyuridine triphosphatase inhibitors (2020-11-10),
14. 10577321 - Deoxyuridine triphosphatase inhibitors (2020-03-03),
15. 10570100 - Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage (2020-02-25),
Company Overview
Cv6 Therapeutics (Ni) Limited is a biotechnology company based in Belfast, specializing in the development of innovative therapeutics aimed at addressing unmet medical needs. The organization focuses on advancing research in areas such as cellular and molecular biology, with an emphasis on creating novel treatments for various diseases. By leveraging cutting-edge technology and scientific expertise, Cv6 Therapeutics aims to contribute significantly to the field of medicine and improve patient outcomes through its specialized therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#5 in Belfast

#1,001 in United Kingdom

#34,263 in the World

Belfast, GB
Belfast, United Kingdom

Cv6 Therapeutics (Ni) Limited

Forward Citations = 113

4 inventors:

goldMedal Mark Spyvee (17 out of 39 patents)

silverMedal Pravin S Shirude (11 out of 11 patents)

bronzeMedal Robert D Ladner (8 out of 14 patents)

4.  Michael D Lewis (1 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cv6 Therapeutics (Ni) Limited. Retrieved from https://idiyas.com/company/cv6-therapeutics-ni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…